CC0651(1319207-44-7)
- Name: CC0651
- Synonyms:CC0651;(2R,3S,4S)-5-[4-(3,5-Dichlorophenyl)phenyl]-2,3-dihydroxy-4-(2-methoxyacetamido)pentanoic acid;4,5-Dideoxy-5-(3',5'-dichloro[1,1'-biphenyl]-4-yl)-4-[(2-methoxyacetyl)amino]-L-arabinonic acid;L-Arabinonic acid, 4,5-dideoxy-5-(3',5'-dichloro[1,1'-biphenyl]-4-yl)-4-[(2-methoxyacetyl)amino]-
- Molecular Formula:C20H21Cl2NO6
- Molecular Weight:442.29
- CAS Registry Number:1319207-44-7
- EINECS:
- Melting Point:
- Water Solubility:
CAS No.1319207-44-7 CC0651
Assay:99.0% Appearance:liquid Package:Grams, Kilograms Storage:Store the container tightly closed in a dry, cool and well-ventilated place. Store apart from foodstuff containers or incompatible materials. Transportation:According to customer request Application:For R&D and commerical use
Min. Order:100Gram
Supplier:Chemlyte Solutions [
China (Mainland)] CAS No.1319207-44-7 L-Arabinonic acid, 4,5-dideoxy-5-(3',5'-dichloro[1,1'-biphenyl]-4-yl)-4-[(2-methoxyacetyl)amino]-
Assay:鈮?5% Appearance:To be subject to the object Package:Customized Transportation:Air Application:pharmaceutical intermediates
Min. Order:0
Supplier:Hangzhou Dingyan Chem Co., Ltd [
China (Mainland)] CAS No.1319207-44-7 CC0651
Assay:95% Appearance:Powder Package:inquiry Storage:-20掳C Freezer Transportation:inquiry Application:CC0651, a Cdc34 ubiquitin-conjugating enzyme allosteric inhibitor, has been found to restrain the cell proliferation at some extent in cancer cell lines PC-3. IC50: 1.72 uM (inhibited the ubiquiti...
Min. Order:0
Supplier:BOC Sciences [
United States]
Other Product
- 1382992-11-1/Benzamide, N-[2-(5-chloro-1H-indol-3-yl)ethyl]-4-[(3-chlorophenyl)methyl]-
- 475205-49-3/A-317491 DISODIUM SALT
- 1396771-17-7/MST1 kinase inhibitor
- 867324-12-7/LBW242
- 902779-59-3/DICHLORO(2Z)-2-[(4-OXO-4H-1-BENZOPYRAN-3-YL)METHYLENE]HYDRAZINECARBOTHIOAMIDE COPPER COMPLEX
- 78780-98-0/1α,25,26-TrihydroxyvitaMin D3
- 473719-41-4/AMG 487
- 936850-11-2/tert-butyl 3-hydroxy-3-(1-hydroxy-2-methylpropan-2-yl)azetidine-1-carboxylate
- 1038410-88-6/JTV 519
- 1352873-82-5/IGF-1R inhibitor
- 1370261-98-5/PRT062607 acetate
- 364762-86-7/TD-198946
- 1228237-47-5/Methanol, 1-[3-[5-[2-[[(3R)-1-[(1-methyl-1H-pyrazol-3-yl)sulfonyl]-3-piperidinyl]amino]-4-pyrimidinyl]imidazo[2,1-b]oxazol-6-yl]phenoxy]-, 1-(dihydrogen phosphate)
- 1186231-83-3/TAK-441
- 1194508-25-2/Edivoxetine
- 159857-81-5/L-Ornithinamide, N-[6-(2,5-dihydro-2,5-dioxo-1H-pyrrol-1-yl)-1-oxohexyl]-L-valyl-N5-(aminocarbonyl)-N-[4-[[[(4-nitrophenoxy)carbonyl]oxy]methyl]phenyl]-
- 956590-23-1/UNBS-5162
- 855527-92-3/NBI-74330
- 1311423-89-8/Benzamide, N-[4-chloro-3-(trifluoromethyl)phenyl]-2-[2-(dimethylamino)ethoxy]-6-ethoxy-
- 1319207-44-7/CC0651
- 406231-90-1/SZ4TA2
- 871266-63-6/PCI-27483
- 891499-69-7/CCR5 antagonist (hydrochloride)
- 308359-57-1/Zalypsis
- 882755-95-5/Phosphonic acid, [5-[2-amino-5-(2,2-dimethyl-1-oxopropyl)-4-thiazolyl]-2-furanyl]-
- 865854-05-3/4-Benzyl-2-(naphthalen-1-yl)-[1,2,4]thiadiazolidine-3,5-dione
- 1233948-61-2/EL-102
- 947257-66-1/D-3263
- 1148115-99-4/UR-63325
- 1415559-43-1/CDK9 inhibitor